Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Campbell, William M
Ferrel, Anne
McLaughlin, John F
Grant, Gerald A
Loeser, John D
Graubert, Catherine
and
Bjornson, Kristie
2002.
Long‐term safety and efficacy of continuous intrathecal baclofen.
Developmental Medicine & Child Neurology,
Vol. 44,
Issue. 10,
p.
660.
Chambers, Henry G.
2002.
Advances in cerebral palsy.
Current Opinion in Orthopaedics,
Vol. 13,
Issue. 6,
p.
424.
Albright, A. Leland
2003.
Neurosurgical Treatment of Spasticity and Other Pediatric Movement Disorders.
Journal of Child Neurology,
Vol. 18,
Issue. 1_suppl,
p.
S67.
O'Flaherty, Stephen
and
Waugh, Mary-Clare
2003.
Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy.
Hand Clinics,
Vol. 19,
Issue. 4,
p.
585.
Sanger, Terence D.
2003.
Pediatric movement disorders.
Current Opinion in Neurology,
Vol. 16,
Issue. 4,
p.
529.
Hansel, Donna E
Hansel, Christian R.W
Shindle, Michael K
Reinhardt, Elsie M
Madden, LaVerne
Levey, Eric B
Johnston, Michael V
and
Hoon, Alexander H
2003.
Oral baclofen in cerebral palsy: possible seizure potentiation?.
Pediatric Neurology,
Vol. 29,
Issue. 3,
p.
203.
Taira, Takaomi
and
Hori, T.
2003.
Neurosurgical Re-Engineering of the Damaged Brain and Spinal Cord.
p.
37.
Sanger, Terence
2003.
Current Opinion in Neurology,
Vol. 16,
Issue. 4,
p.
529.
Lavano, A
Volpentesta, G
Chirchiglia, D
Signorelli, F
Ferraro, G
Veltri, C
Aloisi, M
Piragine, G
and
Iorio, L e
2003.
New Treatments for Severe Intractable Dystonia: Intrathecal Baclofen Therapy (IBT) and Deep Brain Stimulation (DBS) of GPi.
Neuromodulation: Technology at the Neural Interface,
Vol. 6,
Issue. 3,
p.
212.
Nemoto, Akinobu
2003.
Neurosurgical Re-Engineering of the Damaged Brain and Spinal Cord.
p.
39.
Turner, Michael S.
2003.
Neurosurgical Re-Engineering of the Damaged Brain and Spinal Cord.
p.
29.
Kyriagis, M
Grattan‐Smith, P
Scheinberg, A
Teo, C
Nakaji, N
and
Waugh, M
2004.
Status dystonicus and Hallervorden‐Spatz disease: Treatment with intrathecal baclofen and pallidotomy.
Journal of Paediatrics and Child Health,
Vol. 40,
Issue. 5-6,
p.
322.
Dachy, Bernard
and
Dan, Bernard
2004.
Electrophysiological assessment of the effect of intrathecal baclofen in dystonic children.
Clinical Neurophysiology,
Vol. 115,
Issue. 4,
p.
774.
Goldstein, Murray
2004.
The Treatment of cerebral palsy: what we know, what we don't know.
The Journal of Pediatrics,
Vol. 145,
Issue. 2,
p.
S42.
Roubertie, A
Leydet, J
Rivier, F
Humbertclaude, V
Cheminal, R
and
Echenne, B
2004.
Mouvements anormaux de l’enfant : nouveautés thérapeutiques.
Archives de Pédiatrie,
Vol. 11,
Issue. 8,
p.
951.
Bethoux, Francois
2004.
Spasticity patients: special considerations.
Seminars in Pain Medicine,
Vol. 2,
Issue. 1,
p.
36.
Hornby, T. George
Heckman, C. J.
Harvey, Richard L.
and
Rymer, W. Zev
2004.
Changes in voluntary torque and electromyographic activity following oral baclofen.
Muscle & Nerve,
Vol. 30,
Issue. 6,
p.
784.
Abbott, Rick
2004.
Neurosurgical management of abnormal muscle tone in childhood.
Pediatric Clinics of North America,
Vol. 51,
Issue. 2,
p.
457.
Lagarce, Frederic
Faisant, Nathalie
Desfontis, Jean-Claude
Marescaux, Laurent
Gautier, Freddy
Holopherne, Delphine
Rousselet, Marie-Christine
Menei, Philippe
and
Benoit, Jean-Pierre
2005.
Biopharmaceutics of intrathecal baclofen-loaded microparticles in a goat model.
International Journal of Pharmaceutics,
Vol. 298,
Issue. 1,
p.
68.
Albright, A Leland
Ferson, Susan
and
Carlos, Signe
2005.
Occult Hydrocephalus in Children with Cerebral Palsy.
Neurosurgery,
Vol. 56,
Issue. 1,
p.
93.